Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › OH › Poland › NPI 1497289649
Lab

SHC Youngstown Ohio Laboratory Services Company LLC

SHC Youngstown Ohio Laboratory Services Company LLC was paid $3.41M by Medicaid between Jan 2018 and Feb 2024, across 146 billing codes. Its largest line is 82306, Vitamin D; 25 hydroxy, includes fraction(s), if performed — 9.4% of everything it billed.

33Billing provider infoSHC YOUNGSTOWN OHIO LABORATORY SERVICES COMPANY LLC
POLAND, OH 44514
33aNPI1497289649assigned 04/14/2017
28Total paid$3.41M
24GClaims423,615
24DCodes billed146
24AFirst – last monthJan 2018 – Feb 2024
Compared with peers

Next to other Clinical Medical Laboratory providers in Ohio

Rank by total paid#27 of 116
Median peer was paid$313K
This provider vs. median11×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Auditor's notes

Automated statistical signals. Not evidence of fraud — how these are computed.

Entity ProliferationAuthorized official DOYLE, JOHN controls 13+ related entities in our dataset. Read more
Box 24A · Dates of service

Paid by month

$0$25K$50K$75K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
201859,968$490K
201979,665$694K
202078,331$710K
202175,325$642K
202268,720$463K
202353,121$362K
2024incomplete8,485$52K
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed 9.4% 19,768 18,886 $320K
80053 Comprehensive metabolic panel 8.4% 44,376 40,256 $288K
80061 Lipid panel 7.3% 30,559 29,329 $249K
84443 Thyroid stimulating hormone (TSH) 6.7% 23,817 22,655 $227K
85025 Blood count; complete (CBC), automated, and automated differential WBC count 5.6% 39,229 34,666 $191K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe 5.6% 7,068 6,780 $190K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe 5.4% 7,062 6,768 $186K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r 4.2% 2,489 1,270 $143K
83036 Hemoglobin; glycosylated (A1C) 3.6% 22,458 21,526 $124K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 2.7% 2,810 2,438 $93K
87624 Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types 2.6% 3,621 3,531 $90K
80050 General health panel 2.5% 4,628 4,451 $85K
134 more codes
82607 2.1% 8,644 $73K
84439 2.1% 12,585 $71K
88142 2.0% 4,857 $70K
36415 Collection of venous blood by venipuncture 1.7% 35,616 $59K
87086 Culture, bacterial; quantitative colony count, urine 1.5% 10,692 $50K
82746 1.3% 5,742 $46K
87660 1.2% 2,786 $42K
87480 1.2% 2,788 $42K
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies 1.2% 2,305 $40K
82728 <1% 4,204 $34K
87510 <1% 2,571 $34K
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 <1% 1,818 $33K
85027 <1% 8,999 $28K
84153 <1% 2,296 $28K
80074 <1% 1,273 $25K
87186 <1% 4,783 $25K
84403 <1% 1,369 $24K
83735 <1% 5,194 $21K
84481 <1% 1,789 $20K
83540 <1% 4,814 $19K
83550 <1% 3,664 $19K
87661 Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe <1% 1,072 $18K
80048 Basic metabolic panel (calcium, ionized) <1% 4,697 $18K
87070 <1% 2,988 $17K
81513 <1% 177 $15K
84402 <1% 851 $15K
80076 <1% 2,641 $14K
82043 <1% 3,631 $13K
87077 <1% 2,419 $13K
84702 <1% 1,363 $13K
82570 <1% 3,856 $12K
83090 <1% 1,329 $12K
86038 <1% 1,430 $12K
87081 <1% 2,414 $12K
83970 <1% 565 $12K
86140 <1% 4,087 $11K
87590 <1% 581 $10K
81001 <1% 4,824 $9K
86803 <1% 1,062 $9K
84550 <1% 3,004 $8K
88108 <1% 367 $8K
85652 <1% 4,702 $8K
86780 <1% 914 $8K
87088 <1% 1,756 $8K
87205 <1% 2,434 $7K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe <1% 205 $6K
87147 <1% 1,547 $6K
82565 <1% 1,668 $6K
86769 <1% 156 $6K
84100 <1% 2,118 $5K
83690 <1% 1,141 $5K
87808 <1% 483 $5K
85610 <1% 2,883 $5K
82150 <1% 1,009 $4K
86003 <1% 48 $4K
87340 <1% 741 $4K
86762 <1% 455 $4K
83001 <1% 288 $4K
U0002 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc <1% 139 $4K
86787 <1% 332 $4K
86430 <1% 881 $4K
85007 <1% 1,890 $4K
84146 <1% 239 $3K
88112 <1% 144 $3K
84466 <1% 459 $3K
81003 <1% 2,131 $3K
84520 <1% 1,137 $3K
87522 Neg quan hep c or qual rna <1% 102 $3K
83516 <1% 155 $3K
87481 <1% 176 $3K
84480 <1% 273 $3K
83880 <1% 142 $3K
84436 <1% 566 $3K
82248 <1% 720 $2K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type <1% 141 $2K
83721 <1% 808 $2K
83002 <1% 148 $2K
82550 <1% 481 $2K
86592 <1% 561 $2K
83021 <1% 131 $2K
87798 Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism <1% 38 $1K
87801 Infectious agent detection by nucleic acid; amplified probe, multiple organisms <1% 38 $1K
80164 <1% 153 $1K
88175 Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer <1% 61 $1K
82784 <1% 116 $1K
86709 <1% 166 $1K
86705 <1% 156 $1K
86376 <1% 82 $816.39
86480 <1% 30 $736.84
84703 <1% 139 $701.73
86850 <1% 182 $642.09
82731 <1% 12 $628.04
86706 <1% 85 $579.45
84484 <1% 100 $560.48
86593 <1% 203 $530.35
82670 <1% 27 $518.65
85651 <1% 222 $454.97
86901 <1% 251 $426.02
86900 <1% 249 $424.42
87075 <1% 72 $418.47
87625 <1% 27 $418.14
86364 <1% 26 $372.77
80184 <1% 77 $332.49
82785 <1% 27 $330.68
87493 <1% 16 $289.88
86141 <1% 30 $256.11
85730 <1% 92 $241.71
87285 <1% 20 $211.47
86200 <1% 26 $209.44
82977 <1% 39 $204.02
G0476 Infectious agent detection by nucleic acid (dna or rna); human papillomavirus (hpv), high-risk types (e.g., 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 68) for cervical cancer screening, must be performed in addition to pap test <1% 672 $201.68
84156 <1% 81 $184.86
82140 <1% 20 $165.75
85045 <1% 55 $164.28
82247 <1% 41 $160.72
82330 <1% 17 $149.52
82105 <1% 12 $133.45
G0123 Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, screening by cytotechnologist under physician supervision <1% 1,121 $127.19
86735 <1% 13 $126.20
86765 <1% 12 $113.75
83020 <1% 14 $112.42
87335 <1% 13 $107.29
84478 <1% 29 $103.20
G0103 Prostate cancer screening; prostate specific antigen test (psa) <1% 114 $94.26
87045 <1% 13 $84.50
86431 <1% 14 $76.21
84132 <1% 31 $76.15
85018 <1% 58 $48.01
85014 <1% 37 $33.04
80051 <1% 40 $26.48
3046F 0% 254 $0.00
3051F 0% 460 $0.00
3044F 0% 3,263 $0.00
3052F 0% 133 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialDOYLE, JOHN (CFO)
Same official

Other billing entities under DOYLE, JOHN

Full network →

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.